Inovio Pharmaceuticals, Inc.INONASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank43
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-103.20M
↑ 27% vs avg
Percentile
P43
Within normal range
Streak
4 yr
Consecutive growthContracting
Average
$-141.06M
Historical baseline
PeriodValueYoY Change
TTM$-103.20M+0.7%
2024$-103.95M+20.3%
2023$-130.39M+51.9%
2022$-270.90M+8.7%
2021$-296.56M-98.3%
2020$-149.56M-39.3%
2019$-107.34M-19.5%
2018$-89.80M-6.0%
2017$-84.74M-14.3%
2016$-74.15M-